Eric M. Maiese

811 total citations
43 papers, 580 citations indexed

About

Eric M. Maiese is a scholar working on Hematology, Infectious Diseases and Oncology. According to data from OpenAlex, Eric M. Maiese has authored 43 papers receiving a total of 580 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hematology, 10 papers in Infectious Diseases and 9 papers in Oncology. Recurrent topics in Eric M. Maiese's work include Multiple Myeloma Research and Treatments (17 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (8 papers). Eric M. Maiese is often cited by papers focused on Multiple Myeloma Research and Treatments (17 papers), HIV/AIDS drug development and treatment (9 papers) and HIV/AIDS Research and Interventions (8 papers). Eric M. Maiese collaborates with scholars based in United States, United Kingdom and Canada. Eric M. Maiese's co-authors include Girish Prajapati, Imad Al‐Dakkak, Eilish McCann, Seema Patel, Abhijit Gadkari, Felicia Allen‐Ramey, Saad Z. Usmani, Annette Lam, Shiva G. Sajjan and Francisco Noya and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Journal of Allergy and Clinical Immunology.

In The Last Decade

Eric M. Maiese

41 papers receiving 568 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric M. Maiese United States 13 168 163 112 109 75 43 580
Gareth Seaward Canada 17 122 0.7× 84 0.5× 54 0.5× 45 0.4× 118 1.6× 48 951
Kathleen Lang United States 11 205 1.2× 52 0.3× 109 1.0× 160 1.5× 86 1.1× 19 752
Jodi Skiles United States 18 341 2.0× 159 1.0× 138 1.2× 347 3.2× 38 0.5× 53 1.1k
Emmanuel Hatzipantelis Greece 16 122 0.7× 30 0.2× 83 0.7× 112 1.0× 60 0.8× 65 649
Ibrahim Almaghlouth Saudi Arabia 11 97 0.6× 84 0.5× 56 0.5× 46 0.4× 22 0.3× 38 619
Jennifer Welch United States 15 91 0.5× 64 0.4× 25 0.2× 124 1.1× 65 0.9× 56 610
Valerio Cecinati Italy 16 198 1.2× 61 0.4× 74 0.7× 93 0.9× 114 1.5× 61 735
Elizabeth Wastnedge United Kingdom 8 106 0.6× 101 0.6× 72 0.6× 43 0.4× 108 1.4× 11 936
Daniel G. Muenz United States 14 55 0.3× 69 0.4× 27 0.2× 63 0.6× 81 1.1× 23 461
E De Cock United Kingdom 15 78 0.5× 76 0.5× 36 0.3× 172 1.6× 49 0.7× 50 571

Countries citing papers authored by Eric M. Maiese

Since Specialization
Citations

This map shows the geographic impact of Eric M. Maiese's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric M. Maiese with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric M. Maiese more than expected).

Fields of papers citing papers by Eric M. Maiese

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric M. Maiese. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric M. Maiese. The network helps show where Eric M. Maiese may publish in the future.

Co-authorship network of co-authors of Eric M. Maiese

This figure shows the co-authorship network connecting the top 25 collaborators of Eric M. Maiese. A scholar is included among the top collaborators of Eric M. Maiese based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric M. Maiese. Eric M. Maiese is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Coyle, Patricia K., et al.. (2023). Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic. Multiple Sclerosis and Related Disorders. 78. 104881–104881. 2 indexed citations
2.
Hogea, Cosmina, Yevgeniy Samyshkin, Eric M. Maiese, et al.. (2022). An Epidemiology Model for Estimating the Numbers of US Patients With Multiple Myeloma by Line of Therapy and Treatment Exposure. Value in Health. 25(12). 1977–1985. 1 indexed citations
3.
Tosh, Jonathan, Cosmina Hogea, Yevgeniy Samyshkin, et al.. (2021). Budget Impact of Belantamab Mafodotin (Belamaf) Adoption in the Treatment of Patients with Relapsed or Refractory Multiple Myeloma in the United States. ClinicoEconomics and Outcomes Research. Volume 13. 789–800.
4.
Fonseca, Rafaël, Saad Z. Usmani, Maneesha Mehra, et al.. (2020). Frontline treatment patterns and attrition rates by subsequent lines of therapy in patients with newly diagnosed multiple myeloma. BMC Cancer. 20(1). 1087–1087. 67 indexed citations
5.
Durie, Brian G.M., Shaji Kumar, Saad Z. Usmani, et al.. (2020). Daratumumab‐lenalidomide‐dexamethasone vs standard‐of‐care regimens: Efficacy in transplant‐ineligible untreated myeloma. American Journal of Hematology. 95(12). 1486–1494. 26 indexed citations
6.
7.
McKay, Caroline, et al.. (2019). Giving voice to patients: Understanding treatment preferences of patients with multiple myeloma (MM).. Journal of Clinical Oncology. 37(15_suppl). e18302–e18302. 1 indexed citations
8.
Saager, Leif, Eric M. Maiese, Lori D. Bash, et al.. (2018). Incidence, risk factors, and consequences of residual neuromuscular block in the United States: The prospective, observational, multicenter RECITE-US study. Journal of Clinical Anesthesia. 55. 33–41. 64 indexed citations
9.
Maiese, Eric M., et al.. (2018). Comparative Efficacy of Treatments for Previously Treated Multiple Myeloma: A Systematic Literature Review and Network Meta-analysis. Clinical Therapeutics. 40(3). 480–494.e23. 23 indexed citations
10.
Maiese, Eric M., et al.. (2016). Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons. Current Medical Research and Opinion. 32(12). 2039–2046. 14 indexed citations
11.
Saag, Michael S., Andrew O. Westfall, Stephen R. Cole, et al.. (2016). Brief Report: Factors Associated With the Selection of Initial Antiretroviral Therapy From 2009 to 2012. JAIDS Journal of Acquired Immune Deficiency Syndromes. 74(1). 60–64. 5 indexed citations
12.
Muessig, Kathryn E., A. T. Panter, Kathryn E. Stein, et al.. (2015). Medication-Taking Practices of Patients on Antiretroviral HIV Therapy: Control, Power, and Intentionality. AIDS Patient Care and STDs. 29(11). 606–616. 17 indexed citations
13.
Maiese, Eric M., et al.. (2015). Hospital budget impact of sugammadex (Bridionâ®) for Reversal of Neuromuscular Blockade. Value in Health. 18(3). A281–A281. 1 indexed citations
14.
Athanasakis, Kostas, et al.. (2014). Cost-Effectiveness Analysis of Raltegravir in Hiv-Infected Treatment Naive Patients in Greece. Value in Health. 17(7). A675–A675. 1 indexed citations
15.
Maiese, Eric M., Imad Al‐Dakkak, Eilish McCann, et al.. (2012). PIN45 The Impact of HIV Treatment-Related Adverse Events on Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis. Value in Health. 15(4). A245–A245. 2 indexed citations
16.
Al‐Dakkak, Imad, Seema Patel, Eilish McCann, et al.. (2012). The impact of specific HIV treatment-related adverse events on adherence to antiretroviral therapy: A systematic review and meta-analysis. AIDS Care. 25(4). 400–414. 110 indexed citations
17.
Maiese, Eric M., et al.. (2012). Impact of comorbidities on HIV medication persistence: a retrospective database study using US claims data. Journal of the International AIDS Society. 15(S4). 9 indexed citations
18.
Campbell, Jonathan D., Felicia Allen‐Ramey, Shiva G. Sajjan, Eric M. Maiese, & Sean D. Sullivan. (2011). Increasing pharmaceutical copayments: impact on asthma medication utilization and outcomes.. PubMed. 17(10). 703–10. 29 indexed citations
19.
Tseng, Fan‐Chen, Elizabeth E. Brown, Eric M. Maiese, et al.. (2006). Polymorphisms in Cytokine Genes and Risk of Helicobacter pylori Infection among Jamaican Children. Helicobacter. 11(5). 425–430. 33 indexed citations
20.
Gary‐Webb, Tiffany L., et al.. (2005). Patient Satisfaction, Preventive Services, and Emergency Room Use among African-Americans with Type 2 Diabetes. Disease Management. 8(6). 361–371. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gareth Seaward Breakdown of academic impact, for papers by Kathleen Lang Breakdown of academic impact, for papers by Jodi Skiles Breakdown of academic impact, for papers by Emmanuel Hatzipantelis Breakdown of academic impact, for papers by Ibrahim Almaghlouth Breakdown of academic impact, for papers by Jennifer Welch Breakdown of academic impact, for papers by Valerio Cecinati Breakdown of academic impact, for papers by Elizabeth Wastnedge Breakdown of academic impact, for papers by Daniel G. Muenz Breakdown of academic impact, for papers by E De Cock
Rankless by CCL
2026